Venture Capital Funding: Adcendo, Spiral Therapeutics, Anthropic

Tech startups such as Adcendo, Spiral Therapeutics, Anthropic, among others, have announced their venture capital funding to bolster innovation and business growth.

Adcendo Raises $75 mn

Adcendo announced the closing of an oversubscribed $75 million Series C financing round led by Jeito Capital, with participation from Vida Ventures, BPI France, EIFO, and existing investors. The company focuses on developing antibody-drug conjugates (ADCs) for cancer treatment. The funding will support advancement of multiple clinical programs, including ongoing Phase I trials and dose expansion studies across several cancer indications. The company plans to use the proceeds to achieve key clinical milestones and progress its pipeline of targeted therapies. The financing reflects continued investor participation from both new and existing stakeholders, supporting ongoing research and development activities in oncology and precision medicine.

Spiral Therapeutics Secures $27 mn

Spiral Therapeutics announced the completion of a $27 million Series B financing round led by Gund Investment, with participation from Advanced Bionics and other investors. The funding supports development of therapies for inner ear disorders and includes a strategic collaboration with Advanced Bionics. The partnership focuses on combining drug delivery technologies with cochlear implant systems to improve patient outcomes. The capital will be used to advance clinical-stage programs and expand research and development activities. Existing investors also participated in the round. The financing marks a milestone for the company as it progresses its therapeutic pipeline and strengthens collaborations with medical technology partners in hearing and auditory health solutions.

Anthropic Valuation Talks Surge as Claude Demand Drives $800 bn Investor Interest

Anthropic is drawing strong investor attention, with venture capital firms reportedly offering valuations of up to $800 billion, more than double its recent $380 billion valuation. In February, Anthropic raised $30 billion, reflecting growing confidence in its AI capabilities. Demand for its flagship model, Claude, has accelerated sharply, pushing annualized revenue beyond $30 billion in 2026 from $9 billion in 2025. Anthropic is also exploring a potential IPO this year. Meanwhile, its newly launched Mythos model highlights advanced coding and autonomous capabilities, raising both opportunities and cybersecurity concerns.

THASNIYA VP